. . . . . . "1"^^ . . . . . . . "2069"^^ . . "817"^^ . . . . . . . . . . . . . . . . . . . "Dosp\u011Bl\u00ED \nInfekce doln\u00EDho d\u00FDchac\u00EDho traktu zp\u016Fsoben\u00E9 gramnegativn\u00EDmi bakteriemi (viz bod 4.4):\n-\texacerbace chronick\u00E9 obstruktivn\u00ED pulmon\u00E1ln\u00ED nemoci,\n-\tbroncho-pulmon\u00E1ln\u00ED infekce u cystick\u00E9 fibr\u00F3zy nebo u bronchiektazie,\n-\tpneumonie,\nchronick\u00FD hnisav\u00FD z\u00E1n\u011Bt st\u0159edn\u00EDho ucha,\nakutn\u00ED exacerbace chronick\u00E9 sinusitidy, zejm\u00E9na pokud jsou jejich p\u0159\u00ED\u010Dinou gramnegativn\u00ED bakterie,\ninfekce mo\u010Dov\u00FDch cest,\nuretritida a cervicitida zp\u016Fsoben\u00E1 gonokoky citliv\u00FDmi na fluorochinolony,\nepididymo-orchitida, v\u010Detn\u011B p\u0159\u00EDpad\u016F zap\u0159\u00ED\u010Din\u011Bn\u00FDch Neisseria gonorrhoeae,\np\u00E1nevn\u00ED z\u00E1n\u011Btliv\u00E9 onemocn\u011Bn\u00ED (PID), v\u010Detn\u011B p\u0159\u00EDpad\u016F zp\u016Fsoben\u00FDch Neisseria gonorrhoeae,\nU v\u00FD\u0161e uveden\u00FDch infekc\u00ED pohlavn\u00EDho \u00FAstroj\u00ED zp\u016Fsoben\u00FDch Neisseria gonorrhoeae je obzvl\u00E1\u0161t\u011B d\u016Fle\u017Eit\u00E9 z\u00EDskat lok\u00E1ln\u00ED informace o roz\u0161\u00ED\u0159en\u00ED lok\u00E1ln\u00ED rezistence na ciprofloxacin a potvrdit citlivost laboratorn\u00EDmi testy. \ninfekce gastrointestin\u00E1ln\u00EDho traktu (nap\u0159. cestovatelsk\u00FD pr\u016Fjem),\nintraabdomin\u00E1ln\u00ED infekce,\ninfekce k\u016F\u017Ee a m\u011Bkk\u00FDch tk\u00E1n\u00ED zp\u016Fsoben\u00E9 gramnegativn\u00EDmi bakteriemi,\nmalign\u00ED otitis externa,\ninfekce kost\u00ED a kloub\u016F,\ninfekce u pacient\u016F s\u00A0neutropeni\u00ED,\nprofylaxe infekce u pacient\u016F s neutropeni\u00ED,\nprofylaxe invazivn\u00ED infekce zp\u016Fsoben\u00E9 Neisseria meningitidis,\ninhalace antraxu (postexpozi\u010Dn\u00ED profylaxe a kurativn\u00ED l\u00E9\u010Dba)."@cs . . . . . . .